Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option

Author： Cornes Paul Coiffier Bertrand Zambrowski Jean-Jacques

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.2, 2007-02, pp. : 357-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Health Economic Impact of Intravenous Iron Supplementation to Erythropoiesis-Stimulating Agent Treatment in Patients with Cancer- or Chemotherapy-Induced Anemia

Oncology, Vol. 81, Iss. 1, 2011-09 ,pp. : 45-49

Karger

Access to resources Recommend Favorite

Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents

By Mark Tami L. McKenzie R. Scott Fastenau John Piech Catherine Tak

Current Medical Research and Opinion, Vol. 21, Iss. 9, 2005-09 ,pp. : 1347-1354

Informa Healthcare

Access to resources Recommend Favorite

Once-Weekly Treatment of Anemia in Patients with Cancer: A Comparative Review of Epoetins

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 122-129

Karger

Access to resources Recommend Favorite

Prevalence of Anemia in Cancer Patients Undergoing Radiotherapy: Prognostic Significance and Treatment

Oncology, Vol. 63, Iss. 2, 2002-12 ,pp. : 11-18

Karger

Access to resources Recommend Favorite

Fulvestrant: A Further Treatment Option for Patients with Metastatic Uterine Cancer?

Oncology Research and Treatment, Vol. 29, Iss. 12, 2006-12 ,pp. : 577-580

Karger

Access to resources Recommend Favorite